Sofia, Bulgaria, June 10, 2022 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of June 3, 2022, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows:

Sofia, Bulgaria, December 4, 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 1, 2023 the Company bought 66 000 own shares representing 0.0382% of the share capital of the Company, at a total value of BGN 469 600 on the Bulgarian Stock Exchange, the average price per share was BGN 7,12.

Sofia, Bulgaria, June 6, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for May 2022 the Company recorded an increase in sales of 16% compared to the same month of the previous year, incl. 24% decrease in domestic sales and 77% increase in export sales.

For the five months since the beginning of the year the revenues from sales of products increase by 28%, incl. 35% increase of sales for the domestic market and 24% increase in export sales.

Sofia, Bulgaria, June 3, 2022 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para.